Interdisciplinary research brings together imaging, aerosols and pediatric neuro oncology to fight tumors
A person’s brainstem controls some of the body’s most important functions, including heart beat, respiration, blood pressure and swallowing. Tumor growth in this part of the brain is therefore twice as devastating. Not only can such a growth disrupt vital functions, but operating in this area is so risky, many medical professionals refuse to consider it as an option.
New, interdisciplinary research from Washington University in St. Louis has shown a way to target drug delivery to just that area of the brain using noninvasive measures, bolstered by a novel technology: focused ultrasound.
The research comes from the lab of Hong Chen, assistant professor of biomedical engineering in the School of Engineering & Applied Science and assistant professor of radiation oncology at Washington University School of Medicine in St. Louis. Chen has developed a novel way in which ultrasound and its contrast agent — consisting of tiny bubbles — can be paired with intranasal administration, to direct a drug to the brainstem and, potentially, any other part of the brain.
The research, which included faculty from the Mallinckrodt Institute of Radiology and the Department of Pediatrics at the School of Medicine, along with faculty from the Department of Energy, Environmental & Chemical Engineering in the School of Engineering & Applied Science, was published online this week and will be in the Sept. 28 issue of the Journal of Controlled Release.
This technique may bring medicine one step closer to curing brain-based diseases such as diffuse intrinsic pontine gliomas (DIPG), a childhood brain cancer with a five-year survival rate of a scant two percent, a dismal prognosis that has remained unchanged over the past 40 years. (To add perspective, the most common childhood cancer, acute lymphoblastic leukemia, has a five-year survival rate of nearly 90 percent.)
“Each year in the United States, there are no more than 300 cases,” Chen said. “All pediatric diseases are rare; luckily, this is even more rare. But we cannot count numbers in this way, because for kids that have this disease and their families, it is devastating.”
Chen’s technique combines Focused UltraSound with IntraNasal delivery, (FUSIN). The intranasal delivery takes advantage of a unique property of the olfactory and trigeminal nerves: they can carry nanoparticles directly to the brain, bypassing the blood brain barrier, an obstacle to drug delivery in the brain.
This unique capability of intranasal delivery was demonstrated last year by co-authors Ramesh Raliya, research scientist, and Pratim Biswas, assistant vice chancellor and chair of the Department of Energy, Environmental & Chemical Engineering and the Lucy & Stanley Lopata Professor, in their 2017 publication in Scientific Reports.
“At the beginning, I couldn’t even believe this could work,” Hong said of delivering drugs to the brain intranasally. “I thought our brains are fully protected. But these nerves actually directly connect with the brain and provide direct access to the brain.”
While nasal brain drug delivery is a huge step forward, it isn’t yet possible to target a drug to a specific area. Chen’s targeted ultrasound technique is addressing that problem.
When doing an ultrasound scan, the contrast agent used to highlight images is composed of microbubbles. Once injected into the bloodstream, the microbubbles behave like red blood cells, traversing the body as the heart pumps.
Once they reach the site where the ultrasound wave is focused, they do something unusual.
“They start to expand and contract,” Chen said. As they do so, they act as a pump to the surrounding blood vessels as well as the perivascular space — the space surrounding the blood vessels.
“Consider the blood vessels like a river,” Chen said. “The conventional way to deliver drugs is to dump them in the river.” In other parts of the body, the banks of the river are a bit “leaky,” Chen said, allowing the drugs to seep into the surrounding tissue. But the blood brain barrier, which forms a protective layer around blood vessels in the brain, prevents this leakage, particularly in the brains of young patients, such as those with with DIPG.
“We will deliver the drug from the nose to directly outside the river,” Chen said, “in the perivascular space.”
Then, once ultrasound is applied at the brain stem, the microbubbles will begin to expand and contract. The oscillating microbubbles push and pull, pumping the drug toward the brainstem. This technique also addresses the problem of drug toxicity — the drugs will go directly to the brain instead of circulating through the whole body. In collaboration with Yongjian Liu, associate professor of radiology, and Yuan-Chuan Tai, associate professor of radiology, Chen used positron emission tomography (PET scan) to verify that there was minimal accumulation of intranasal-administered nanoparticles in major organs, including lungs, liver, spleen, kidney and heart.
So far, Chen’s lab has had success using their technique in mice for the delivery of gold nanoclusters made by the team led by Liu.
“The next step is to demonstrate the therapeutic efficacy of FUSIN in the delivery of chemotherapy drugs for the treatment of DIPG,” said Dezhuang Ye, lead author of the paper, who is Chen’s graduate student from the Department of Mechanical Engineering & Materials Science. The lab has also teamed up with Biswas to develop a new aerosol nasal delivery device to scale up the technique from a mouse to a large animal model.
Chen’s lab collaborated on this research with pediatric neuro-oncologist Joshua Rubin, MD, PhD, professor of pediatrics at the School of Medicine who treats patients at St. Louis Children’s Hospital. Chen said the team hopes to translate the findings of this study into clinical trials for children with DIPG.
There are difficulties ahead, but Chen believes researchers will need to continue to innovate when it comes to solving such a difficult problem as treating DIPG.
Learn more: Focused delivery for brain cancers
The Latest on: Blood-brain barrier
via Google News
The Latest on: Blood-brain barrier
- Research Offers New Clues on How Manganese Enters Brain on September 14, 2018 at 10:37 am
Her poster, titled “The Regulatory Mechanisms of Manganese Flux Into the Brain Via the Blood-Brain Barrier,” outlined how proteins transport manganese in the brain. Steimle conducts research in in the ... […]
- Newly formed blood vessels may contribute to eye disease on September 14, 2018 at 5:09 am
This selective protein permeability is a feature of several other barriers across the body, including the blood-brain barrier and blood-placental barrier. Jeffrey Savas, Ph.D., assistant professor ... […]
- Portsmouth woman succumbs to unusual disease on September 13, 2018 at 7:11 am
Albanian doctor Dritan Agalliu was one of the first to identify PANDAS. A neurologist, his area of study was the blood brain barrier and the mechanism that could breach it. PANDAS Network estimates th... […]
- VC-backed Travecta taps Hicks as chief business officer on September 13, 2018 at 7:07 am
PHILADELPHIA–(BUSINESS WIRE)–Travecta Therapeutics, an emerging biotech company developing a platform that leverages its proprietary knowledge of the MFSD2a Transport for the targeted delivery of ther... […]
- Travecta Therapeutics Appoints Douglas C. Hicks as Chief Business Officer on September 13, 2018 at 6:12 am
“Doug joins our team at a critical time, as we continue to develop our internal pipeline and begin to establish external partnerships of our novel platform, which assists companies in delivering their ... […]
- Microbubble technology bypasses blood brain barrier, says researcher on September 11, 2018 at 7:00 am
A study at Washington University in St. Louis has shown a new way to deliver drugs to the brainstem in a non-invasive administration: microbubbles and ultrasound. Hong Chen, assistant professor at Was... […]
- Blood-Brain Barrier Transport Drugs Market Overview – Global and Regional Forecast to 2025 on September 7, 2018 at 4:16 am
A new market study, titled “Global Blood-Brain Barrier Transport Drugs Market Insights, Forecast to 2025” has been featured on WiseGuyReports. This report studies the global market size of Blood-Brain ... […]
- Ultrasound jiggles open brain barrier, a step to better care on September 7, 2018 at 12:46 am
The so-called blood-brain barrier prevents germs and other damaging substances from leaching in through the bloodstream — but it can block drugs for Alzheimer's, brain tumors and other neurologic dise... […]
- Study: Breaking Blood-Brain Barrier to Treat Brain Diseases on August 30, 2018 at 3:20 pm
The code has been copied to your clipboard. The URL has been copied to your clipboard From VOA Learning English, this is the Health & Lifestyle report. Our brains are protected by our skull. But that ... […]
via Bing News